Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Beck

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Preparing for the End GameWilliam T Beck
Cancers|March 13, 2024
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to TherapyRyungsa Kim, Takanori Kin, William T Beck
The Journal of Biological Chemistry|March 26, 2005
Identification of estrogen-responsive genes using a genome-wide analysis of promoter elements for transcription factor binding sitesSitharthan Kamalakaran, Senthil K Radhakrishnan, William T Beck
Molecular Cancer Therapeutics|June 19, 2007
Gam1-associated alterations of drug responsiveness through activation of apoptosisFangting Wu, Susanna Chiocca, William T Beck, et al.
The Journal of Biological Chemistry|November 16, 2001
Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the proteinYin-Yuan Mo, Yanni Yu, Zhiyuan Shen, et al.
International Journal of Biochemistry and Molecular Biology|August 30, 2016
Transient resistance to DNA damaging agents is associated with expression of microRNAs-135b and -196b in human leukemia cell linesTsui-Ting Ho, Xiaolong He, Yin-Yuan Mo, et al.
Molecular Cancer Therapeutics|January 7, 2005
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interferenceP L Rachel Ee, Xiaolong He, Douglas D Ross, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Tumor cell resistance to DNA topoisomerase II inhibitors: new developmentsWilliam T. Beck, Susan E. Morgan, Yin-Yuan Mo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20Xiaolong He, P L Rachel Ee, John S Coon, et al.
Cancer Research|April 17, 2004
Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugsYin-Yuan Mo, Yanni Yu, P L Rachel Ee, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Preparing for the End GameWilliam T Beck
Cancers|March 13, 2024
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to TherapyRyungsa Kim, Takanori Kin, William T Beck
The Journal of Biological Chemistry|March 26, 2005
Identification of estrogen-responsive genes using a genome-wide analysis of promoter elements for transcription factor binding sitesSitharthan Kamalakaran, Senthil K Radhakrishnan, William T Beck
Molecular Cancer Therapeutics|June 19, 2007
Gam1-associated alterations of drug responsiveness through activation of apoptosisFangting Wu, Susanna Chiocca, William T Beck, et al.
The Journal of Biological Chemistry|November 16, 2001
Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the proteinYin-Yuan Mo, Yanni Yu, Zhiyuan Shen, et al.
International Journal of Biochemistry and Molecular Biology|August 30, 2016
Transient resistance to DNA damaging agents is associated with expression of microRNAs-135b and -196b in human leukemia cell linesTsui-Ting Ho, Xiaolong He, Yin-Yuan Mo, et al.
Molecular Cancer Therapeutics|January 7, 2005
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interferenceP L Rachel Ee, Xiaolong He, Douglas D Ross, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Tumor cell resistance to DNA topoisomerase II inhibitors: new developmentsWilliam T. Beck, Susan E. Morgan, Yin-Yuan Mo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20Xiaolong He, P L Rachel Ee, John S Coon, et al.
Cancer Research|April 17, 2004
Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugsYin-Yuan Mo, Yanni Yu, P L Rachel Ee, et al.
Pageof 3